There are currently 15 active clinical trials seeking participants for Hepatic Impairment research studies. The states with the highest number of trials for Autism participants are Florida, Texas, California and Minnesota.
Hepatic Impairment, Cholestatic Liver Disease, & NASH With Advanced Fibrosis & Normal Hepatic Function
NCT04469920
Recruiting
This will be a Phase 1, Open-label Study of Participants with Hepatic Impairment, Cholestatic Liver Disease, and NASH with Advanced Fibrosis and Normal Hepatic Function
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/06/2023
Locations: Indiana University School of Medicine, Indianapolis, Indiana +1 locations
Conditions: Hepatic Impairment
Register for Updates
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
NCT05045482
Recruiting
A Phase 1, Open-label Extension Groups Study in Subjects having Hepatic Impairment with Cirrhosis due to Cholestatic Liver Disease
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/06/2023
Locations: Indiana University, Indianapolis, Indiana
Conditions: Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease
Register for Updates
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
NCT05484206
Recruiting
In this study, a single dose of VIR-2218 up to 200 mg SC or VIR-3434 at 300 mg SC monotherapy or a combination of VIR-2218 and VIR-3434 will be administered to assess the pharmacokinetic (PK) exposure, safety, and tolerability of VIR-2218 and VIR-3434 in participants with cirrhosis and Hepatic Impairment, defined using the Child-Pugh-Turcotte (CPT) categorization.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
04/03/2023
Locations: Inland Empire Clinical Trials, Rialto, California +4 locations
Conditions: Hepatic Impairment, Cirrhosis
Register for Updates